全文获取类型
收费全文 | 3240篇 |
免费 | 101篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 113篇 |
妇产科学 | 148篇 |
基础医学 | 194篇 |
口腔科学 | 13篇 |
临床医学 | 146篇 |
内科学 | 829篇 |
皮肤病学 | 30篇 |
神经病学 | 595篇 |
特种医学 | 69篇 |
外科学 | 437篇 |
综合类 | 23篇 |
预防医学 | 173篇 |
眼科学 | 73篇 |
药学 | 66篇 |
中国医学 | 17篇 |
肿瘤学 | 395篇 |
出版年
2023年 | 49篇 |
2022年 | 104篇 |
2021年 | 121篇 |
2020年 | 105篇 |
2019年 | 343篇 |
2018年 | 345篇 |
2017年 | 151篇 |
2016年 | 70篇 |
2015年 | 72篇 |
2014年 | 281篇 |
2013年 | 215篇 |
2012年 | 132篇 |
2011年 | 227篇 |
2010年 | 209篇 |
2009年 | 112篇 |
2008年 | 127篇 |
2007年 | 112篇 |
2006年 | 80篇 |
2005年 | 95篇 |
2004年 | 59篇 |
2003年 | 57篇 |
2002年 | 32篇 |
2001年 | 9篇 |
2000年 | 10篇 |
1999年 | 9篇 |
1998年 | 13篇 |
1997年 | 8篇 |
1996年 | 7篇 |
1995年 | 5篇 |
1994年 | 2篇 |
1993年 | 2篇 |
1992年 | 1篇 |
1991年 | 1篇 |
1990年 | 2篇 |
1988年 | 1篇 |
1985年 | 30篇 |
1984年 | 13篇 |
1983年 | 21篇 |
1982年 | 17篇 |
1981年 | 24篇 |
1980年 | 14篇 |
1979年 | 15篇 |
1978年 | 8篇 |
1977年 | 12篇 |
1976年 | 6篇 |
1975年 | 5篇 |
1974年 | 8篇 |
1973年 | 2篇 |
1971年 | 1篇 |
排序方式: 共有3344条查询结果,搜索用时 78 毫秒
1.
《Cancer radiothérapie》2022,26(4):611-615
In order to provide more convenient irradiation regimens for patient comfort, radiation facility organization and health expenses, new hypofractionated protocols have been evaluated. Moderately (dose/fraction: 2.3 to 3 Gy), then ultra (dose/fraction: 5.2 to 6.1 Gy) hypofractionated irradiations were first validated. The current question is: is it possible to go forward using extreme hypofractionated regimens (EHR) based on 1 to 3 fractions. Different irradiation techniques are under investigation. However, brachytherapy remains the smartest way to deliver a high dose in a small volume. We report prospective and retrospective study results which evaluated EHR for breast and prostate brachytherapy. While oncological outcome and toxicity profile appear extremely encouraging for low-risk breast cancer after a 1 to 4 fractions (6.25 to 20 Gy/fraction), the use of a single fraction of 19 to 23 Gy appears debatable for prostate cancer. Brachytherapy represents an emblematic example of EHR but longer follow-up and more mature results are awaited in order to specify the right indications and refine the EQD2 calculation method including new biological and technical factors. 相似文献
2.
Adjuvant irradiation is the standard treatment after breast conservative surgery. Normofractionated regimen with an overall treatment time of 5 to 6 weeks is often considered as a limiting factor for irradiation compliance. In order to answer this issue, moderate and more recently extreme hypofractionated protocols appeared. We report here oncological outcomes and toxicity of hypofractionated breast irradiation. After defining the frame of moderate and extreme hypofractionated breast irradiations based on overall treatment time, patient selection criteria were listed. According to their levels of proof, the results of moderate and extreme hypofractionated breast irradiation were analysed. Overall treatment time for moderate hypofractionated breast irradiation ranged from 3 to 4 weeks, while for extreme hypofractionated breast irradiation, it was less than 1 week. For moderate hypofractionated breast irradiation, whole breast irradiation was currently performed with or without lymph node irradiation. Moderate hypofractionated breast irradiation has proven to be as safe and as efficient as normofractionated breast irradiation with level IA evidence. For extreme hypofractionated breast irradiation, phase III randomized trials confirmed that accelerated partial breast irradiation was non-inferior in terms of local control compared to normofractionated whole breast irradiation (with external beam radiation therapy and multicatheter brachytherapy), with similar acute and late toxicity. While the use of intraoperative breast irradiation remains under debate, new very accelerated partial breast irradiation (overall treatment time not exceeding 2 days) protocols emerged with encouraging results. Accelerated partial breast irradiation is warranted for extreme hypofractionated breast irradiation and is indicated for low-risk breast cancers. Moderate and extreme hypofractionated breast irradiation regimens are validated and can be routinely proposed according to patient selection criteria. 相似文献
3.
4.
5.
6.
7.
8.
《ALTER. European Journal of Disability research, Journal europeen de recherche sur le handicap》2019,13(2):113-125
The aim of this article is to examine how different ideological perspectives on Swedish disability policy, are reflected in the experiences of disabled people and their families personal assistants. Personal assistance provided within the family can be seen as a hybridization between publicly regulated and paid work performed in the private family sphere, and thus conflicting norms and practices may coexist. In Sweden, family members of the assistant user can be employed as paid personal assistants. Many users combine personal assistance from family members with non-family assistance. Approximately 20–25% of the employed personal assistants are relatives of the assistance users. The empirical data consists of qualitative interviews with seventeen adult users and twenty-three family members employed as PAs with different types of family ties; parent-child relationships, sibling relationships and partner relationships. The findings show that family assistance could entail advantages such as personalised services, to combine instrumental and emotional assistance as well as achieving a power-balance between the parties. But there were also disadvantages, such as unwanted or enforced dependency, with a risk for both parties to be ‘locked up’ in the family. In an overall analysis, we distinguished three broad approaches towards family assistance, family as a substitute, family as a supplement and family first. 相似文献
9.
10.